HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

PLoS One. 2017 Mar 21;12(3):e0173943. doi: 10.1371/journal.pone.0173943. eCollection 2017.

Abstract

Background: There are several contributors to HIV-pathogenesis or insufficient control of the infection. However, whether HIV/HCV-coinfected population exhibits worst evolution of HIV-pathogenesis remains unclear. Recently, some markers of immune exhaustion have been proposed as preferentially upregulated on T-cells during HIV-infection. Herein, we have analyzed T-cell exhaustion together with several other contributors to HIV-pathogenesis that could be affected by HCV-coinfection.

Patients and methods: Ninety-six patients with chronic HIV-infection (60 HIV-monoinfected and 36 HIV/HCV-coinfected), and 20 healthy controls were included in the study. All patients were untreated for both infections. Several CD4 and CD8 T-cell subsets involved in HIV-pathogenesis were investigated. Non-parametric tests were used to establish differences between groups and associations between variables. Multivariate linear regression was used to ascertain the variables independently associated with CD4 counts.

Results: HIV-patients presented significant differences compared to healthy controls in most of the parameters analyzed. Both HIV and HIV/HCV groups were comparable in terms of age, CD4 counts and HIV-viremia. Compared to HIV group, HIV/HCV group presented significantly higher levels of exhaustion (Tim3+PD1- subset) in total CD8+ T-cells (p = 0.003), and higher levels of exhaustion in CD8+HLADR+CD38+ (p = 0.04), CD8+HLADR-CD38+ (p = 0.009) and CD8+HLADR-CD38- (p = 0.006) subsets of CD8+ T-cells. Interestingly these differences were maintained after adjusting by CD4 counts and HIV-viremia.

Conclusions: We show a significant impact of HCV-coinfection on CD8 T-cells exhaustion, an important parameter associated with CD8 T-cell dysfunction in the setting of chronic HIV-infection. The relevance of this phenomenon on immunological and/or clinical HIV progression prompts HCV treatment to improve management of coinfected patients.

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • Case-Control Studies
  • Coinfection / etiology
  • Coinfection / immunology*
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • HIV Infections / complications*
  • HIV Infections / etiology
  • HIV Infections / immunology*
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / immunology*
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Statistics, Nonparametric
  • Viral Load / immunology

Grants and funding

This study has been funded by projects: RD12/0017/0031 and PI14/00518 integrated in the Plan Nacional I+D+I and co-funded by ISCIII-Subdirección General de Evaluación and European Regional Development Fund (Fondos FEDER). Norma Rallón is a Miguel Servet investigator from the ISCIII (CP14/00198), Madrid, Spain. M García is a predoctoral student co-funded by CP14/00198 project and Intramural Research Scholarship from IIS-FJD. N Rodriguez and C Restrepo are funded by project RD12/0017/0031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.